Clinical Trial Update: Blood Biomarkers for Screening of Alzheimer's Disease

View source ↗

Summary

A recruiting clinical trial from Peking University First Hospital is evaluating blood biomarkers to screen for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Peking University First Hospital | Conditions: Alzheimer's Disease, Blood Biomarkers | Status: RECRUITING